Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Thyroid Neoplasms 1Sarcoma, Ewing 1Pain 1Osteosarcoma 1Osteonecrosis 1Nasopharyngeal Carcinoma 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphedema 1Leukemia 1Hodgkin Disease 1Exostoses, Multiple Hereditary 1Deglutition Disorders 1Colonic Neoplasms 1Chondrosarcoma 1Breast Neoplasms 1Bone Neoplasms 1Anemia, Sickle Cell 1

Interventions

Cyclophosphamide 165fludarabine phosphate 110Peripheral Blood Stem Cell Transplantation 94Mycophenolic Acid 88Whole-Body Irradiation 81Etoposide 81Tacrolimus 73Busulfan 68Melphalan 67Filgrastim 66fludarabine 62Radiotherapy 56Doxorubicin 54Cyclosporine 54Rituximab 50Brentuximab Vedotin 48Antilymphocyte Serum 47Granulocyte Colony-Stimulating Factor 42Vinblastine 41Methotrexate 38Dacarbazine 37Cytarabine 35Gemcitabine 34Nivolumab 30Bleomycin 29Carmustine 28Vincristine 25Prednisone 25Sirolimus 24Bendamustine Hydrochloride 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hodgkin Disease × Range of Motion, Articular × Clear all
NCT02458937 2018-11-13

Functional Outcomes Following Hip Core Decompression in Younger Participants With Osteonecrosis

St. Jude Children's Research Hospital

Completed
17 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Sickle Cell, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Osteonecrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡